{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:13:34Z","timestamp":1778822014490,"version":"3.51.4"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["1400-3-101-56299"],"award-info":[{"award-number":["1400-3-101-56299"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.intimp.2022.109147","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T13:35:40Z","timestamp":1660397740000},"page":"109147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Elevated neopterin in tuberculosis and co-infection with HIV and the effect of treatment: A systematic review, meta-analysis, and meta-regression"],"prefix":"10.1016","volume":"111","author":[{"given":"Amene","family":"Saghazadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.intimp.2022.109147_b0005","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S1473-3099(18)30625-X","article-title":"Global, regional, and national burden of tuberculosis, 1990\u20132016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study","volume":"18","author":"Kyu","year":"2018","journal-title":"Lancet. Infect. Dis"},{"issue":"9","key":"10.1016\/j.intimp.2022.109147_b0010","doi-asserted-by":"crossref","first-page":"e898","DOI":"10.1016\/S2214-109X(17)30289-9","article-title":"The global burden of tuberculosis mortality in children: a mathematical modelling study","volume":"5","author":"Dodd","year":"2017","journal-title":"Lancet Global Health"},{"issue":"3","key":"10.1016\/j.intimp.2022.109147_b0015","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00655-2019","article-title":"The global prevalence of latent tuberculosis: a systematic review and meta-analysis","volume":"54","author":"Cohen","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.intimp.2022.109147_b0020","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1590\/s1806-37562017000000443","article-title":"Risk factors for tuberculosis: diabetes, smoking, alcohol use, and the use of other drugs","volume":"44","author":"Silva","year":"2018","journal-title":"J. Brasileiro de Pneumologia"},{"issue":"12","key":"10.1016\/j.intimp.2022.109147_b0025","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.it.2016.09.007","article-title":"Tuberculosis: an infection-initiated autoimmune disease?","volume":"37","author":"Elkington","year":"2016","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109147_b0030","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1164\/ajrccm.157.3.9705044","article-title":"Local immune responses correlate with presentation and outcome in tuberculosis","volume":"157","author":"Condos","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.intimp.2022.109147_b0035","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1473-3099(13)70015-X","article-title":"Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts","volume":"13","author":"Marais","year":"2013","journal-title":"Lancet. Infect. Dis"},{"key":"10.1016\/j.intimp.2022.109147_b0040","article-title":"Tuberculosis diagnosis\u2014time for a game change","author":"Small","year":"2010","journal-title":"Mass Medical Soc"},{"key":"10.1016\/j.intimp.2022.109147_b0045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0065-2423(08)60182-1","article-title":"Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application","volume":"27","author":"Wachter","year":"1989","journal-title":"Adv. Clin. Chem."},{"issue":"7","key":"10.1016\/j.intimp.2022.109147_b0050","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"issue":"7","key":"10.1016\/j.intimp.2022.109147_b0055","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.intimp.2022.109147_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med. Res. Method."},{"issue":"4","key":"10.1016\/j.intimp.2022.109147_b0065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evidence-based Mental Health"},{"issue":"1","key":"10.1016\/j.intimp.2022.109147_b0070","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12874-015-0091-1","article-title":"Hartung-Knapp-Sidik-Jonkman approach and its modification for random-effects meta-analysis with few studies","volume":"15","author":"R\u00f6ver","year":"2015","journal-title":"BMC Med. Res. Method."},{"issue":"1","key":"10.1016\/j.intimp.2022.109147_b0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jrsm.1316","article-title":"A comparison of heterogeneity variance estimators in simulated random-effects meta-analyses","volume":"10","author":"Langan","year":"2019","journal-title":"Res. Synthesis Methods"},{"issue":"1","key":"10.1016\/j.intimp.2022.109147_b0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method","volume":"14","author":"IntHout","year":"2014","journal-title":"BMC Med. Res. Method."},{"key":"10.1016\/j.intimp.2022.109147_b0085","series-title":"Introduction to meta-analysis","author":"Borenstein","year":"2021"},{"issue":"2","key":"10.1016\/j.intimp.2022.109147_b0090","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3102\/10769986006002107","article-title":"Distribution theory for Glass\u2019s estimator of effect size and related estimators","volume":"6","author":"Hedges","year":"1981","journal-title":"J. Educational Statistics"},{"key":"10.1016\/j.intimp.2022.109147_b0095","doi-asserted-by":"crossref","unstructured":"J. Cohen, Statistical power analysis for the behavioral sciences, Academic press, 2013.","DOI":"10.4324\/9780203771587"},{"issue":"7109","key":"10.1016\/j.intimp.2022.109147_b0100","first-page":"629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clin. Res. Ed.)"},{"issue":"2","key":"10.1016\/j.intimp.2022.109147_b0105","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot\u2013based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"issue":"11","key":"10.1016\/j.intimp.2022.109147_b0110","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jclinepi.2010.08.010","article-title":"Conducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care Program","volume":"64","author":"Fu","year":"2011","journal-title":"J. Clin. Epidemiol."},{"issue":"9540","key":"10.1016\/j.intimp.2022.109147_b0115","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0140-6736(06)69342-2","article-title":"Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum","volume":"368","author":"Agranoff","year":"2006","journal-title":"Lancet (London, England)"},{"issue":"4","key":"10.1016\/j.intimp.2022.109147_b0120","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1620\/tjem.218.285","article-title":"Persistent elevation of plasma osteopontin levels in HIV patients despite highly active antiretroviral therapy","volume":"218","author":"Chagan-Yasutan","year":"2009","journal-title":"Tohoku J. Exp. Med."},{"issue":"6","key":"10.1016\/j.intimp.2022.109147_b0125","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1164\/ajrccm\/139.6.1474","article-title":"Urinary neopterin in pulmonary sarcoidosis. Relationship to clinical and biologic assessment of the disease","volume":"139","author":"Lacronique","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"issue":"4","key":"10.1016\/j.intimp.2022.109147_b0130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s12291-018-0741-2","article-title":"Ophthalmic presentation of disseminated tuberculosis with relapse-immunological profile","volume":"33","author":"Kashyap","year":"2018","journal-title":"Indian J. Clin. Biochem. IJCB"},{"issue":"2","key":"10.1016\/j.intimp.2022.109147_b0135","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1515\/pteridines.1990.2.2.87","article-title":"Is neopterin helpful in distinguishing between different disease patterns in AIDS?","volume":"2","author":"Zangerle","year":"1990","journal-title":"Pteridines"},{"key":"10.1016\/j.intimp.2022.109147_b0140","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-10-333","article-title":"IP-10 detection in urine is associated with lung diseases","volume":"10","author":"Cannas","year":"2010","journal-title":"BMC Infect. Dis."},{"issue":"12","key":"10.1016\/j.intimp.2022.109147_b0145","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.5588\/ijtld.16.0159","article-title":"Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis","volume":"20","author":"Singanayagam","year":"2016","journal-title":"Int. J. Tuberculosis Lung Dis."},{"issue":"4","key":"10.1016\/j.intimp.2022.109147_b0150","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s00420-003-0434-9","article-title":"Neopterin as a new biomarker for the evaluation of occupational exposure to silica","volume":"76","author":"Altindag","year":"2003","journal-title":"Int. Arch. Occup. Environ. Health"},{"issue":"2","key":"10.1016\/j.intimp.2022.109147_b0155","first-page":"78","article-title":"Levels of procalcitonin, C-reactive protein and neopterin in patients with advanced HIV-1 infection, Southern African","volume":"13","author":"Bipath","year":"2012","journal-title":"J. HIV Med."},{"key":"10.1016\/j.intimp.2022.109147_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2018.00181","article-title":"Macrophage activation marker neopterin: a candidate biomarker for treatment response and relapse in visceral leishmaniasis","volume":"8","author":"Kip","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109147_b0165","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1515\/pteridines.2009.20.1.119","article-title":"Neopterin concentration in serum and chosen markers of inflammatory process in children with acute diarrhea caused by Rotavirus or Salmonella","volume":"20","author":"Kozlowska-Murawska","year":"2009","journal-title":"Pteridines"},{"issue":"3","key":"10.1016\/j.intimp.2022.109147_b0170","first-page":"380","article-title":"Plasma neopterin and peroxide levels in pulmonary tuberculosis patients on chemotherapy with or without micronutrient supplementation","volume":"25","author":"Akiibinu","year":"2009","journal-title":"Pakistan J. Medical Sci."},{"issue":"11","key":"10.1016\/j.intimp.2022.109147_b0175","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/qjmed\/89.11.831","article-title":"Systemic immune activation as a potential determinant of wasting in Zambians with HIV-related diarrhoea","volume":"89","author":"Kelly","year":"1996","journal-title":"QJM: Monthly J. Assoc. Physicians"},{"issue":"11","key":"10.1016\/j.intimp.2022.109147_b0180","doi-asserted-by":"crossref","first-page":"e0166301","DOI":"10.1371\/journal.pone.0166301","article-title":"Elevated Neopterin Levels Are Associated with Increased Tuberculosis Risk in Rheumatoid Arthritis Patients with QuantiFERON Conversion during Biologic Therapy","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.intimp.2022.109147_b0185","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/PL00007615","article-title":"Neopterin levels and pulmonary tuberculosis in infants","volume":"176","author":"Horak","year":"1998","journal-title":"Lung"},{"issue":"2","key":"10.1016\/j.intimp.2022.109147_b0190","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1515\/pteridines.1994.5.2.61","article-title":"Neopterin determinations in tuberculous bone infections","volume":"5","author":"Peterss","year":"1994","journal-title":"Pteridines"},{"issue":"11","key":"10.1016\/j.intimp.2022.109147_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049658","article-title":"Rapid diagnostic algorithms as a screening tool for tuberculosis: an assessor blinded cross-sectional study","volume":"7","author":"Ratzinger","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2022.109147_b0200","article-title":"Comparison of serum neopterin levels in pulmonary tuberculosis patients with positive acid fast bacilli and inactive pulmonary tuberculosis","volume":"18","author":"Soedarsono","year":"2020","journal-title":"J. Clin. Tuberculosis Mycobacterial Dis."},{"issue":"3","key":"10.1016\/j.intimp.2022.109147_b0205","first-page":"301","article-title":"Peculiarities of functional activity of circulating phagocytes in patients with different forms of drug-resistant pulmonary tuberculosis, Biochemistry (Moscow) Supplement Series B: Biomedical","volume":"5","author":"Titarenko","year":"2011","journal-title":"Chemistry"},{"issue":"6","key":"10.1016\/j.intimp.2022.109147_b0210","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0962-8479(96)90049-0","article-title":"Immune activation, allergic drug toxicity and mortality in HIV-positive tuberculosis","volume":"77","author":"Wallis","year":"1996","journal-title":"Tubercle Lung Dis.: Official J. Int. Union against Tuberculosis Lung Dis."},{"issue":"2","key":"10.1016\/j.intimp.2022.109147_b0215","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00002030-200401230-00015","article-title":"A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis","volume":"18","author":"Wallis","year":"2004","journal-title":"AIDS (London, England)"},{"issue":"3","key":"10.1016\/j.intimp.2022.109147_b0220","first-page":"150","article-title":"Neopterin, soluble interleukin-2 receptor and adenosine deaminase levels in pleural effusions","volume":"61","author":"Chiang","year":"1994","journal-title":"Respiration; Int. Rev. Thoracic Dis."},{"issue":"10","key":"10.1016\/j.intimp.2022.109147_b0225","first-page":"1267","article-title":"Circulating cytokines in pulmonary tuberculosis according to HIV status and dietary iron content","volume":"13","author":"Gordeuk","year":"2009","journal-title":"Int. J. Tuberculosis Lung Dis.: The Official J. Int. Union against Tuberculosis Lung Dis."},{"issue":"7","key":"10.1016\/j.intimp.2022.109147_b0230","first-page":"648","article-title":"Neopterin and oxidative stress markers in the diagnosis of extrapulmonary tuberculosis","volume":"22","author":"Goyal","year":"2017","journal-title":"Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals"},{"issue":"4","key":"10.1016\/j.intimp.2022.109147_b0235","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12291-016-0624-3","article-title":"Comparative Diagnostic Utility of Neopterin and IFN-\u03b3\/IL-2 in Extrapulmonary Tuberculosis","volume":"32","author":"Goyal","year":"2017","journal-title":"Indian J. Clin. Biochem.: IJCB"},{"issue":"2","key":"10.1016\/j.intimp.2022.109147_b0240","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00002030-200101260-00011","article-title":"Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected zambian adults","volume":"15","author":"Quigley","year":"2001","journal-title":"AIDS (London, England)"},{"key":"10.1016\/j.intimp.2022.109147_b0245","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ebiom.2017.10.018","article-title":"Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial","volume":"25","author":"Sigal","year":"2017","journal-title":"EBioMedicine"},{"issue":"18","key":"10.1016\/j.intimp.2022.109147_b0250","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136301","article-title":"Urinary biomarkers of mycobacterial load and treatment response in pulmonary tuberculosis","volume":"5","author":"Xia","year":"2020","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.intimp.2022.109147_b0255","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11828-008-1014-z","article-title":"Functional activity of phagocytes of bronchoalveolar lavage in patients with fibro-cavernous and infiltrative pulmonary tuberculosis","volume":"2","author":"Dyakova","year":"2008","journal-title":"Biochem. (Moscow) Supplement Ser. B: Biomed. Chem."},{"issue":"5","key":"10.1016\/j.intimp.2022.109147_b0260","first-page":"21","article-title":"The comparative value of quantiferonic test, neopterin and specific anti-tuberculosis antibodies in clinical diagnostic of tuberculosis of lungs","author":"Vasiliyeva","year":"2013","journal-title":"Klin. Lab. Diagn."},{"issue":"3","key":"10.1016\/j.intimp.2022.109147_b0265","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.clim.2009.02.003","article-title":"Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy","volume":"131","author":"Iyer","year":"2009","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109147_b0270","first-page":"213","article-title":"Levels of oxidative metabolites, antioxidants and neopterin in Nigerian pulmonary tuberculosis patients","volume":"8","author":"Akiibinu","year":"2011","journal-title":"Eur. J. General Med."},{"issue":"6","key":"10.1016\/j.intimp.2022.109147_b0275","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/ajcp\/101.6.719","article-title":"Use of discriminant analysis to assess disease activity in pulmonary tuberculosis with a panel of specific and nonspecific serum markers","volume":"101","author":"Ameglio","year":"1994","journal-title":"Am. J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109147_b0280","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00174318","article-title":"Neopterin in tuberculous and neoplastic pleural fluids","volume":"170","author":"Baganha","year":"1992","journal-title":"Lung"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2022.109147_b0285","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0022-1759(00)00148-4","article-title":"Simple dipstick assay for semi-quantitative detection of neopterin in sera","volume":"238","author":"B\u00fchrer-Sekula","year":"2000","journal-title":"J. Immunol. Methods"},{"issue":"5","key":"10.1016\/j.intimp.2022.109147_b0290","doi-asserted-by":"crossref","first-page":"366","DOI":"10.7883\/yoken.JJID.2008.366","article-title":"Assessment of diagnostic enzyme-linked immunosorbent assay kit and serological markers in human brucellosis","volume":"61","author":"Cakan","year":"2008","journal-title":"Japanese J. Infectious Dis."},{"issue":"3","key":"10.1016\/j.intimp.2022.109147_b0295","first-page":"134","article-title":"The diagnostic value of the measurement of neopterin concentrations in body fluids for pulmonary tuberculosis","volume":"34","author":"\u00c7ayci","year":"2009","journal-title":"Turkish J. Biochem."},{"issue":"1","key":"10.1016\/j.intimp.2022.109147_b0300","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijmyco.2014.01.002","article-title":"Clinical importance of serum neopterin level in patients with pulmonary tuberculosis","volume":"3","author":"Cesur","year":"2014","journal-title":"Int. J. Mycobacteriol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109147_b0305","first-page":"327","article-title":"Evaluating the validity of serum neopterin in the diagnosis of pulmonary tuberculosis infection with different severities","volume":"27","author":"Chao","year":"2012","journal-title":"\u80f8\u8154\u91ab\u5b78"},{"issue":"1","key":"10.1016\/j.intimp.2022.109147_b0310","first-page":"15","article-title":"Serum neopterin, soluble interleukin 2-receptor (sIL-2R\u03b1) and lung computed tomography in differentiation between pulmonary tuberculosis and bronchogenic carcinoma","volume":"30","author":"El Kholy Omayma","year":"2006","journal-title":"Biochimica Clinica"},{"issue":"2","key":"10.1016\/j.intimp.2022.109147_b0315","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4103\/1687-8426.184360","article-title":"Serum neopterin level in cases of pulmonary tuberculosis and pneumonia","volume":"10","author":"El-Shimy","year":"2016","journal-title":"Egyptian J. Bronchol."},{"key":"10.1016\/j.intimp.2022.109147_b0320","unstructured":"M. Ghonaim, R. El-Edel, A.R. El-Arbagy, Soluble Interleukin-2 Receptor Alpha (s i L-2R a) and Neopterin In Patients With Pulmonary Tuberculosis."},{"issue":"4","key":"10.1016\/j.intimp.2022.109147_b0325","first-page":"330","article-title":"The role of serum neopterin level in the evaluation of activation and response to treatment in the patients with pulmonary tuberculosis","volume":"54","author":"G\u00fcler","year":"2006","journal-title":"Tuberkuloz ve toraks"},{"issue":"5","key":"10.1016\/j.intimp.2022.109147_b0330","first-page":"548","article-title":"Incomplete immunological recovery following anti-tuberculosis treatment in HIV-infected individuals with active tuberculosis","volume":"129","author":"Hanna","year":"2009","journal-title":"Indian J. Med. Res."},{"issue":"6","key":"10.1016\/j.intimp.2022.109147_b0335","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1086\/315114","article-title":"Depressed T-cell interferon-\u03b3 responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy","volume":"180","author":"Hirsch","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.intimp.2022.109147_b0340","unstructured":"O.O. Hovardovska, The role of serum neopterin level in the monitoring of treatment for pulmonary tuberculosis, 2018."},{"issue":"2","key":"10.1016\/j.intimp.2022.109147_b0345","first-page":"185","article-title":"Serial evaluation of serum neopterin in HIV seronegative patients treated for tuberculosis","volume":"5","author":"Immanuel","year":"2001","journal-title":"Int. J. Tuberculosis Lung Dis.: The Official J. Int. Union against Tuberculosis Lung Dis."},{"issue":"2","key":"10.1016\/j.intimp.2022.109147_b0350","first-page":"175","article-title":"Neopterin as a marker for cell-mediated immunity in patients with pulmonary tuberculosis","volume":"1","author":"Immanuel","year":"1997","journal-title":"Int. J. Tuberculosis Lung Dis.: The Official J. Int. Union against Tuberculosis Lung Dis."},{"issue":"4","key":"10.1016\/j.intimp.2022.109147_b0355","first-page":"220","article-title":"Serum neopterin levels in HIV infected patients with & without tuberculosis","volume":"121","author":"Immanuel","year":"2005","journal-title":"Indian J. Medical Res."},{"issue":"2","key":"10.1016\/j.intimp.2022.109147_b0360","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.diagmicrobio.2007.04.019","article-title":"Value of serum procalcitonin, neopterin, and C-reactive protein in differentiating bacterial from viral etiologies in patients presenting with lower respiratory tract infections","volume":"59","author":"Ip","year":"2007","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"3","key":"10.1016\/j.intimp.2022.109147_b0365","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s12291-017-0686-x","article-title":"Diagnostic Potential of Circulating Biomarkers in Adenosine Deaminase Diagnosed Pleural Tuberculosis Cases","volume":"33","author":"Kashyap","year":"2018","journal-title":"Indian J. Clin. Biochem.: IJCB"},{"issue":"3","key":"10.1016\/j.intimp.2022.109147_b0370","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1378\/chest.119.3.776","article-title":"BAL neopterin - A novel marker for cell-mediated immunity in patients with pulmonary tuberculosis and lung cancer","volume":"119","author":"Mohamed","year":"2001","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.intimp.2022.109147_b0375","article-title":"Evaluating the diagnostic value of serum neopterin levels for pulmonary tuberculosis","volume":"6H","author":"Mousavi","year":"2019","journal-title":"Ambient Sci."},{"issue":"12","key":"10.1016\/j.intimp.2022.109147_b0380","first-page":"Cr521-524","article-title":"Serum neopterin concentrations in healthy healthcare workers compared with healthy controls and patients with pulmonary tuberculosis","volume":"12","author":"Ozdemir","year":"2006","journal-title":"Medical science monitor: Int. Med. J. Experimental Clin. Res."},{"issue":"3","key":"10.1016\/j.intimp.2022.109147_b0385","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jinf.2005.05.019","article-title":"Procalcitonin and neopterin correlation with aetiology and severity of pneumonia","volume":"52","author":"Prat","year":"2006","journal-title":"J. Infection"},{"issue":"3","key":"10.1016\/j.intimp.2022.109147_b0390","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4046\/trd.2002.53.3.294","article-title":"Soluble IL-2R, IFN-\u03b3 and neopterin as immunologic markers in patients with tuberculosis","volume":"53","author":"Ryu","year":"2002","journal-title":"Tuberculosis Respir. Dis."},{"issue":"7","key":"10.1016\/j.intimp.2022.109147_b0395","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jcp.44.7.596","article-title":"Serum C-reactive protein and neopterin concentration in patients with viral or bacterial infection","volume":"44","author":"Shaw","year":"1991","journal-title":"J. Clin. Pathol."},{"issue":"10","key":"10.1016\/j.intimp.2022.109147_b0400","first-page":"1071","article-title":"Significance of serum neopterin level in diagnosis of active pulmonary tuberculosis","volume":"36","author":"Shi","year":"2011","journal-title":"Med. J. Chinese People\u2019s Liberation Army"},{"issue":"12","key":"10.1016\/j.intimp.2022.109147_b0405","doi-asserted-by":"crossref","first-page":"e0144292","DOI":"10.1371\/journal.pone.0144292","article-title":"Plasma Levels of Neopterin and C-Reactive Protein (CRP) in Tuberculosis (TB) with and without HIV Coinfection in Relation to CD4 Cell Count","volume":"10","author":"Skogmar","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2022.109147_b0410","doi-asserted-by":"crossref","first-page":"S578","DOI":"10.1016\/S0924-8579(07)71848-4","article-title":"Diagnostic value of neopterin in patients with active pulmonary tuberculosis and relation with CRP","volume":"29","author":"Tarhan","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"4","key":"10.1016\/j.intimp.2022.109147_b0415","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1620\/tjem.209.321","article-title":"Serum interleukin-2 and neopterin levels as useful markers for treatment of active pulmonary tuberculosis","volume":"209","author":"Turgut","year":"2006","journal-title":"Tohoku J. Experimental Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.109147_b0420","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1365-2249.1996.907600.x","article-title":"Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection","volume":"103","author":"Vanham","year":"1996","journal-title":"Clin. Exp. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2022.109147_b0425","first-page":"771","article-title":"Urinary neopterin measurement as a non-invasive diagnostic method in pulmonary tuberculosis","volume":"7","author":"Yuksekol","year":"2003","journal-title":"Int. J. Tuberculosis Lung Dis.: The Official J. Int. Union against Tuberculosis Lung Dis."},{"issue":"4","key":"10.1016\/j.intimp.2022.109147_b0430","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/PL00007573","article-title":"Neopterin, \u03b22-microglobulin, and acute phase proteins in HIV-1- seropositive and -seronegative Zambian patients with tuberculosis","volume":"175","author":"Hosp","year":"1997","journal-title":"Lung"},{"issue":"4","key":"10.1016\/j.intimp.2022.109147_b0435","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.tube.2015.04.011","article-title":"C. Tuberculosis Trials, Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis","volume":"95","author":"Jayakumar","year":"2015","journal-title":"Tuberculosis"},{"key":"10.1016\/j.intimp.2022.109147_b0440","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12879-016-1447-9","article-title":"C-reactive protein, Neopterin and Beta2 microglobulin levels pre and post TB treatment in The Gambia","volume":"16","author":"Mendy","year":"2016","journal-title":"BMC Infect. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2022.109147_b0445","first-page":"14","article-title":"Neopterin in serum - A method for determination the activity of tuberculous disease in children","volume":"31","author":"Minchev","year":"2004","journal-title":"Acta Medica Bulgarica"},{"issue":"2","key":"10.1016\/j.intimp.2022.109147_b0450","doi-asserted-by":"crossref","first-page":"334","DOI":"10.4314\/ahs.v15i2.5","article-title":"A non-specific biomarker of disease activity in HIV\/AIDS patients from resource-limited environments","volume":"15","author":"Bipath","year":"2015","journal-title":"African Health Sci."},{"key":"10.1016\/j.intimp.2022.109147_b0455","article-title":"Plasma levels of CRP, neopterin and IP-10 in HIV-infected individuals with and without pulmonary tuberculosis","volume":"16","author":"Ciccacci","year":"2019","journal-title":"J. Clin. Tuberculosis Mycobacterial Dis."},{"key":"10.1016\/j.intimp.2022.109147_b0460","doi-asserted-by":"crossref","unstructured":"U. Esther, B.S. Bagaya, B. Castelnuovo, D.P. Kateete, A. Godwin, N. Kiwanuka, C.C. Whalen, M. Joloba, Heme Oxygenase-1 and Neopterin Plasma\/Serum Levels and their role in Diagnosing Active and Latent TB among HIV\/TB Co-Infected Patients, 2019.","DOI":"10.21203\/rs.2.14803\/v1"},{"issue":"4","key":"10.1016\/j.intimp.2022.109147_b0465","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/QAD.0000000000000557","article-title":"Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome","volume":"29","author":"Tan","year":"2015","journal-title":"AIDS (London, England)"},{"issue":"2","key":"10.1016\/j.intimp.2022.109147_b0470","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/jmv.20257","article-title":"Changes in HIV RNA viral load, CD4+ T-cell counts, and levels of immune activation markers associated with anti-tuberculosis therapy and cotrimoxazole prophylaxis among HIV-infected tuberculosis patients in Abidjan","volume":"75","author":"Kalou","year":"2005","journal-title":"C\u00f4te d\u2019Ivoire, Journal of medical virology"},{"issue":"12","key":"10.1016\/j.intimp.2022.109147_b0475","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.clinbiochem.2007.04.009","article-title":"Pleural fluid neopterin levels in tuberculous pleurisy","volume":"40","author":"Cok","year":"2007","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.intimp.2022.109147_b0480","doi-asserted-by":"crossref","unstructured":"F. Duksal, \u0130. D\u00f6ngel, F. Duksal, A. Hazar, Place of neopterin level in the differential diagnosis of tuberculosis pleurisy, Basic Clin. Sci. 2(2) 65-70.","DOI":"10.12808\/bcs.v2i2.27"},{"issue":"2","key":"10.1016\/j.intimp.2022.109147_b0485","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5152\/ttd.2010.03","article-title":"The diagnostic value of pleural fluid neopterin level in tuberculous pleurisy","volume":"11","author":"Erol","year":"2010","journal-title":"Turk Toraks Dergisi"},{"issue":"4","key":"10.1016\/j.intimp.2022.109147_b0490","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5578\/tt.9973","article-title":"The comparative value of pleural fluid adenosine deaminase and neopterin levels in diagnostic utility of pleural tuberculosis","volume":"63","author":"Ko\u015far","year":"2015","journal-title":"Tuberkuloz ve toraks"},{"issue":"9","key":"10.1016\/j.intimp.2022.109147_b0495","first-page":"1040","article-title":"The diagnostic values of serum, pleural fluid and urine neopterin measurements in tuberculous pleurisy","volume":"9","author":"Tozkoparan","year":"2005","journal-title":"Int. J. Tuberculosis Lung Dis.: The Official J. Int. Union against Tuberculosis Lung Dis."},{"key":"10.1016\/j.intimp.2022.109147_b0500","doi-asserted-by":"crossref","first-page":"5643853","DOI":"10.1155\/2016\/5643853","article-title":"Determination of urinary neopterin\/creatinine ratio to distinguish active tuberculosis from latent mycobacterium tuberculosis infection","volume":"2016","author":"Eisenhut","year":"2016","journal-title":"J. Biomarkers"},{"issue":"6","key":"10.1016\/j.intimp.2022.109147_b0505","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF02715666","article-title":"Neopterin as an index of immune response in patients with tuberculosis","volume":"162","author":"Fuchs","year":"1984","journal-title":"Lung"},{"key":"10.1016\/j.intimp.2022.109147_b0510","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ebiom.2018.04.014","article-title":"Mass spectrometric identification of urinary biomarkers of pulmonary tuberculosis","volume":"31","author":"Isa","year":"2018","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.intimp.2022.109147_b0515","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4046\/trd.1986.33.4.202","article-title":"Neopterin as an activity index in pulmonary tuberculosis","volume":"33","author":"Song","year":"1986","journal-title":"Tuberculosis Respir. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2022.109147_b0520","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1084\/jem.160.1.310","article-title":"Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma","volume":"160","author":"Huber","year":"1984","journal-title":"J. Experimental Med."},{"issue":"6","key":"10.1016\/j.intimp.2022.109147_b0525","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.intimp.2022.109147_b0530","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"Cooper","year":"1993","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.intimp.2022.109147_b0535","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1128\/iai.65.12.5149-5156.1997","article-title":"Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis","volume":"65","author":"Fenton","year":"1997","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.intimp.2022.109147_b0540","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0889-1591(02)00006-5","article-title":"Neopterin production, tryptophan degradation, and mental depression\u2014what is the link?","volume":"16","author":"Widner","year":"2002","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.intimp.2022.109147_b0545","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2478\/jomb-2018-0004","article-title":"Potential prognostic role of immune system activation marker neopterin in patients with type 2 diabetes","volume":"37","author":"\u00dcn\u00fcvar","year":"2018","journal-title":"J. Med. Biochem."},{"issue":"4","key":"10.1016\/j.intimp.2022.109147_b0550","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1034\/j.1399-6576.2002.460412.x","article-title":"Procalcitonin and neopterin as indicators of infection in critically ill patients","volume":"46","author":"Ruokonen","year":"2002","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.intimp.2022.109147_b0555","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/196432","article-title":"Neopterin in diagnosis and monitoring of infectious diseases","volume":"2013","author":"Eisenhut","year":"2013","journal-title":"J. Biomarkers"},{"issue":"5","key":"10.1016\/j.intimp.2022.109147_b0560","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/1097-0142(19850301)55:5<1052::AID-CNCR2820550521>3.0.CO;2-9","article-title":"Significance of urinary neopterin in patients with malignant tumors of the genitourinary tract","volume":"55","author":"Aulitzky","year":"1985","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.intimp.2022.109147_b0565","first-page":"225","article-title":"Serum neopterin levels in haematological malignancies","volume":"78","author":"Caenazzo","year":"1993","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.intimp.2022.109147_b0570","first-page":"EE01-EE6","article-title":"Laboratory Diagnosis of Extra-pulmonary Tuberculosis (EPTB) in Resource-constrained Setting: State of the Art, Challenges and the Need","volume":"9","author":"Purohit","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"issue":"3","key":"10.1016\/j.intimp.2022.109147_b0575","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-0625.1999.tb00367.x","article-title":"Neopterin: a review","volume":"8","author":"Hamerlinck","year":"1999","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.intimp.2022.109147_b0580","unstructured":"W.H. Organization, Tuberculosis Most affected groups and areas, 2021."},{"key":"10.1016\/j.intimp.2022.109147_b0585","unstructured":"G.T.R. World Health Organization, Incidence of tuberculosis (per 100,000 people), (2021)."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922006312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922006312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:51:56Z","timestamp":1778820716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922006312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":117,"alternative-id":["S1567576922006312"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109147","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated neopterin in tuberculosis and co-infection with HIV and the effect of treatment: A systematic review, meta-analysis, and meta-regression","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109147","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109147"}}